This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results- 5Corabian, Paula
- 3Chojecki, Dagmara
- 3Harstall, Christa
- 2Yan, Charles
- 1Akpinar, Ilke
- 1Chuck, Anderson
- 1Automated auditory brainstem response
- 1Automated evoked otoacoustic emissions
- 1Blood spot screening
- 1Congenital hearing impairment
- 1Congenital hearing loss
- 1Hearing tests - Safety
- 3Institute of Health Economics
- 2Institute of Health Economics/Social, Technological and Economic (STE) Report (IHE)
- 2Alberta Heritage Foundation for Medical Research (AHFMR)
- 1Institute of Health Economics/Exploratory Brief (IHE)
- 1Alberta Heritage Foundation for Medical Research (AHFMR)/Information Paper (AHFMR)
- 1Alberta Heritage Foundation for Medical Research (AHFMR)/HTA Report (AHFMR)
-
Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Health Care
Download2012-03-01
Chojecki, Dagmara, Harstall, Christa, Corabian, Paula
This exploratory report provides a summary of some of the published information on the current status of research in and potential future sphere of activity of nanomedicine (Part I) and an inventory of resources on nanotechnology and nanomedicine (Part II). Over the next 5 to 10 years it is...
-
Newborn blood spot screening for galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease, and severe combined immunodeficiency
Download2016-03-23
Waye, Arianna, El Shayeb, Mohamed, Guo, Bing, Chuck, Anderson, Akpinar, Ilke, Chojecki, Dagmara, Yan, Charles, Corabian, Paula
This STE report examines the safety, screening accuracy, therapeutic efficacy/effectiveness, cost-effectiveness, budget impact, and health system readiness of newborn screening for seven conditions (galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle...
-
2004-05-01
Harstall, Christa, Corabian, Paula
The objective of this report was to conduct a systematic review of the published research on the use of sclerotherapy to manage varicose veins of the legs. The intent of this paper was to answer the following questions: Is sclerotherapy effective for varicose veins of the legs and if so, is one...
-
THE SAFETY AND EFFICACY/ EFFECTIVENESS OF USING AUTOMATED TESTING DEVICES FOR UNIVERSAL NEWBORN HEARING SCREENING: AN UPDATE
Download2012-10-14
Institute of Health Economics, Chojecki, Dagmara, Harstall, Christa, Yan, Charles, Chuck, Anderson (Andy), Corabian, Paula
This report is an update of a 2007 report. Permanent congenital hearing impairment/loss (PCHI/PCHL) is one of the most common congenital anomalies found at birth which can lead to delays and deficits in the development of speech, language, cognition, and learning, as well as secondary effects on...
-
2001-03-01
Leggett Tait, Patricia, Corabian, Paula
This report has been produced in response to a request from Alberta Health and Wellness for an update on the use of vagus nerve stimulation (VNS) for refractory epilepsy. The intent was to inform health policy makers, medical practitioners, and the public on the current status of the use of VNS...